Citius Pharmaceuticals, Inc. — Director's Dealing 2021

Jul 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Citius Pharmaceuticals, Inc. (CTXR)
CIK: 0001506251
Period of Report: 2021-07-22

Reporting Person: Bartushak Jaime (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-22	Stock Option (Right to Purchase Common Stock)	$2.00	A	100000	Acquired	2031-07-22	Common Stock (100000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	60353	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Purchase Common Stock)	$1.01	2030-10-06	Common Stock (125000)	125000	Direct
Stock Option (Right to Purchase Common Stock)	$0.67	2029-10-08	Common Stock (100000)	100000	Direct
Stock Option (Right to Purchase Common Stock)	$1.62	2028-09-04	Common Stock (70000)	70000	Direct
Stock Option (Right to Purchase Common Stock)	$3.45	2027-09-15	Common Stock (25000)	25000	Direct
Stock Option (Right to Purchase Common Stock)	$10.5	2026-07-06	Common Stock (48267)	48267	Direct

Footnotes

F1: The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.

F2: The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date

F3: The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.

F4: One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, September 4, 2018, provided that the Optionee provides Continuous Service to the Company on each such vesting date.

F5: On September 15, 2017 the Reporting Person was granted a ten-year option to purchase 25,000 shares of common stock at an exercise price of $3.45 per share. The options vest as follows: 8,333 shares vest on September 13, 2018, and then 694 shares per month for the next 24 months.

F6: On July 6, 2016 the Reporting Person was granted a ten-year option to purchase 48,267 shares of common stock at an exercise price of $10.50 per share. The options vest as follows: 16,089 shares vest on July 7, 2017, and then 1,341 shares per month for the next 24 months.